Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2012 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

Components of
DT Vaccine

Excipients Table
Allergens Table
Components Table

 

Indication

To prevent infection with Corynebacterium diphtheriae and Clostridium tetani.

Proprietary Name

DT (generic)

Manufacturer

sanofi pasteur

Viability

Inactivated

Approved Ages 7 years 

Dose

0.5 mL

Route

Intramuscular

Dose form

Suspension

Appearance

Turbid liquid, white, slightly gray

Concentration (per 0.5 mL)

Diphtheria, 6.7 Lf U

Tetanus, 5 LF U

Excipients

Aluminum, ≤ 0.17 mg

Bovine Extract, amount not specified in Package Insert

Formaldehyde, <0.02%

Adjuvant

Aluminum potassium sulfate, 0.17 mg aluminum

Allergens

Stopper to the vial contains dry natural latex rubber

Thimerosal, ≤0.3 mcg mercury

Preservatives

Thimerosal, ≤0.3 mcg mercury

Media

Modified Mueller and Miller

Pepton-based medium containing bovine extract

Packaging

Single-dose (0.5 mL) vials - 10 per package

Routine storage

2 to 8° C (36-46° F)

Do Not Freeze

Package Insert Date December 2005

updated January 2012

This page was last updated on April 05, 2012

© 2012 Institute for Vaccine Safety